Overview

Decitabine Versus Supportive Care in Adults With Advanced-stage MDS

Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
To compare the safety and efficacy profiles of decitabine to those of supportive care in adults with advanced-stage myelodysplastic syndrome (MDS)
Phase:
Phase 3
Details
Lead Sponsor:
Astex Pharmaceuticals
Astex Pharmaceuticals, Inc.
Treatments:
Azacitidine
Decitabine